Inovio Pharma (INO) Data Reported Was Positive, "Terrific Vaccine in a World of Unknowns" - Stifel

May 24, 2017 11:08 AM

Stifel maintains Buy on Inovio Pharmaceuticals (NASDAQ: INO) price target of $11.00.Analyst Dr. Tom Shrader comments on two positives from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found